GangaGen Secures Additional US$7.9M from CARB-X for Pre-clinical Development of Novel Klebicins Targ

New funding will help tackle multidrug-resistant Klebsiella pneumoniae. BANGALORE, India, Dec. 19, 2024 /PRNewswire/ -- GangaGen is pleased to announce today ... Read more

Bron:

Lifestyle